UnknownPHASE1, PHASE2NCT00003942

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Studying HIV-associated cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Systemix
Principal Investigator
Tyler Martin, MD
Systemix
Intervention
RevM10 gene(biological)
Enrollment
15 enrolled
Eligibility
18 years · All sexes
Timeline
1998

Study locations (6)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00003942 on ClinicalTrials.gov

Other trials for HIV-associated cancer

Additional recruiting or active studies for the same condition.

See all trials for HIV-associated cancer

← Back to all trials